(GU) Working Group
LEADING EXPERTS
The Saudi Genitourinary (GU) Working Group
This platform was created as a comprehensive resource for clinicians managing urothelial and prostate cancers, offering access to clinical protocols, molecular updates, treatment algorithms, and educational content curated by experts from across the Kingdom.
WHAT WE DO?
Engaging webinars
Live or recorded online sessions where experts share insights, practical knowledge, and interactive discussions with participants.
Our core focus
Educational content
healthcare professionals
Prostate Cancer
Prostate cancer stands as the second most prevalent cancer affecting males worldwide.
Bladder cancer
Bladder cancer has moved up from the 10th to the 9th most diagnosed cancer worldwide, with both incidence and mortality rates increasing
Urothelial Cancer
Urothelial carcinoma, also known as transitional cell carcinoma (TCC), primarily affects the bladder but can also occur in the upper urinary tract .
WHAT WE DO?
We envision a future in which every healthcare provider is empowered with the knowledge and resources necessary to deliver exceptional care for patients with GU cancers. Through collaboration and ongoing education, we are providing a community of dedicated professionals committed to transforming patient lives for the better. Our offerings include engaging webinars and seminars, informative conferences, insightful podcasts, and compelling testimonials from experts in the field.
Our initiatives focus on
- Disseminating the latest molecular and clinical insights in urothelial and prostate cancer.
- Promoting multidisciplinary case discussions and expert consensus on best practices.
- Developing localized clinical guidelines and decision-support tools.
- Supporting collaborative research to address region-specific challenges and patient needs.
